Silence Therapeutics Plc (SLN)
Silence Therapeutics - Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
Silence Therapeutics - Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical